Search Results
Oct 23, 2025, 02:33 ET SASOL LIMITED: BUSINESS PERFORMANCE METRICS FOR THE THREE MONTHS ENDED 30 SEPTEMBER 2025
targets. Specifically, the Southern Africa value chain breakeven oil price for Q1 FY26 is in line with our market guidance of US$55 - 60/bbl, supported by higher production volumes, disciplined cost and capital management. International Chemicals is on track to meet the adjusted EBITDA target
More news about: Sasol Limited
Oct 21, 2025, 16:30 ET EQT Reports Third Quarter 2025 Results
NGLs price ($/Bbl)
More news about: EQT Corporation (EQT-IR)
Oct 21, 2025, 08:00 ET CROSS TIMBERS ROYALTY TRUST DECLARES OCTOBER CASH DISTRIBUTION
Oil (per Bbl)
More news about: Cross Timbers Royalty Trust
Oct 21, 2025, 08:00 ET PERMIAN BASIN ROYALTY TRUST ANNOUNCES OCTOBER CASH DISTRIBUTION, EXCESS COST POSITION ON WADDELL RANCH PROPERTIES AND NOTICE OF SPECIAL MEETING CALLED BY SOFTVEST
Trust's allocated portion of the Texas Royalty Properties was 14,323 barrels of oil and 11,709 Mcf of gas. The average price for oil was $65.08 per bbl and for gas was $8.10, which includes significant NGL pricing, per Mcf. This would mainly reflect production and pricing in July for oil and June for
More news about: Permian Basin Royalty Trust
Oct 21, 2025, 06:30 ET PermRock Royalty Trust Declares Monthly Cash Distribution
(per Bbl)
More news about: PermRock Royalty Trust
Oct 16, 2025, 06:05 ET Biocon Biologics and Civica Expand Partnership and Launch Private-Label Insulin Glargine to Broaden U.S. Diabetes Treatment Options
BRIDGEWATER, N.J. and BENGALURU, India, Oct. 16, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), today announced expansion of its strategic
More news about: Biocon Biologics
Oct 15, 2025, 07:00 ET Origin Agritech Executes Northeast China Market Re-Entry with Product Showcase and Technology Seminar
Platform ProgressR&D Director Bill Deng provided updates on Origin's transgenic technology platform, highlighting the advancement of the BBL2-2 event. China Agricultural University Professor Feng Tian presented gene editing applications developed in collaboration with Origin, demonstrating
More news about: Origin Agritech Limited
Oct 10, 2025, 16:47 ET Strathcona Resources Ltd. Terminates Take-Over Bid for MEG Energy Corp., Announces Shareholder Meeting to Approve Special Distribution, and Provides Corporate Update
are shown in barrels (bbl), including those derived from natural gas. Natural gas equivalency volumes for purposes of reporting production or "boe" (barrels of oil equivalent) have been derived using the ratio of six thousand cubic feet of gas to one barrel of oil (6 Mcf: 1 bbl). Such figures may be misleading,
More news about: Strathcona Resources Ltd.
Oct 03, 2025, 08:00 ET SABINE ROYALTY TRUST ANNOUNCES MONTHLY CASH DISTRIBUTION FOR OCTOBER 2025
Oil (per bbl)
More news about: Sabine Royalty Trust
Oct 01, 2025, 07:30 ET Biocon Biologics Secures U.S. Market Entry Date for Bosaya™ and Aukelso™, Denosumab Biosimilars
BENGALURU, India and BRIDGEWATER, N.J., Oct. 1, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE: 532523, NSE: BIOCON), today announced a settlement and license
More news about: Biocon Biologics
Sep 19, 2025, 09:17 ET PermRock Royalty Trust Declares Monthly Cash Distribution
(per Bbl)
More news about: PermRock Royalty Trust
Sep 19, 2025, 08:00 ET CROSS TIMBERS ROYALTY TRUST DECLARES SEPTEMBER CASH DISTRIBUTION
Oil (per Bbl) Gas
More news about: Cross Timbers Royalty Trust
Sep 19, 2025, 08:00 ET PERMIAN BASIN ROYALTY TRUST ANNOUNCES SEPTEMBER CASH DISTRIBUTION, EXCESS COST POSITION ON WADDELL RANCH PROPERTIES AND SETTLEMENT OF LAWSUIT
the Texas Royalty Properties was 13,944 barrels of oil and 10,800 Mcf of gas. The average price for oil was $65.76 per bbl and for gas was $6.65, which includes significant NGL pricing, per Mcf. This would mainly reflect production and pricing
More news about: Permian Basin Royalty Trust
Sep 17, 2025, 07:32 ET Biocon Biologics Receives U.S. Food and Drug Administration Approval for Bosaya™ and Aukelso™, Denosumab Biosimilars
BRIDGEWATER, N.J., Sept. 17, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE: 532523, NSE: BIOCON), today announced that the U.S. Food and Drug
More news about: Biocon Biologics
Sep 15, 2025, 19:29 ET EHSLeaders Launches CoreSkills: Interactive Leadership Workshops to Help EHS Professionals Build Resilience and Drive Change
MS, CSP, CIT, Safety Management Consultant, MEMICGabe Encarnacion, President, Bennett-Bowen & Lighthouse (BBL Safety)Josh Russell, CSP, Director of EHS, Howard Hughes Medical Institute"CoreSkills equips EHS
More news about: EHSLeaders